selected scholarly activity
-
academic article
- An interpretive descriptive approach of patients with osteoporosis and integrating osteoporosis management advice into their lifestyle. International Journal of Qualitative Studies on Health and Well-being. 17:2070976. 2022
- A retrospective observational study of osteoporosis management after a fragility fracture in primary care. Archives of Osteoporosis. 17:75. 2022
- Response to Letter to the Editor From Taguchi: “Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS”. Journal of Clinical Endocrinology and Metabolism. 107:e2651-e2652. 2022
- Directive clinique no 422g : Ménopause et ostéoporose. Journal of Obstetrics and Gynaecology Canada. 44:537-546.e5. 2022
- Guideline No. 422g: Menopause and Osteoporosis. Journal of Obstetrics and Gynaecology Canada. 44:527-536.e5. 2022
- Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS. Journal of Clinical Endocrinology and Metabolism. 107:1441-1460. 2022
- An Interpretive Descriptive Approach to Understanding Osteoporosis Management from the Perspective of People at Risk of Fracturing. Patient Preference and Adherence. Volume 16:1673-1686. 2022
- PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism. Journal of Clinical Endocrinology and Metabolism. 107:e372-e385. 2022
- Hypercalcemia in Pregnancy. Endocrinology and Metabolism Clinics of North America. 50:753-768. 2021
- Osteoporosis treatment rate following hip fracture in a community hospital. Archives of Osteoporosis. 16:8. 2021
- The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics. BMC Endocrine Disorders. 21:232. 2021
- Primary Hyperparathyroidism in Pregnancy: Literature Review of the Diagnosis and Management. Journal of Clinical Medicine Journal of Clinical Medicine Journal of Clinical Medicine. 10:2956-2956. 2021
- Atypical Presentation of Familial Hypocalciuric Hypercalcemia: Case Report. Journal of the Endocrine Society. 5:A182-A183. 2021
- Delayed Diagnosis of Congenital Hypoparathyroidism in a Kindred of Three Patients With Autosomal Dominant Deafness. Journal of the Endocrine Society. 5:A189-A189. 2021
- Efficacy of Low Dose Denosumab in Maintaining Bone Mineral Density in Postmenopausal Women With Osteoporosis Switching From 60mg to 30mg 6 Monthly: A Real World, Prospective Observational Study. Journal of the Endocrine Society. 5:A240-A241. 2021
- Canadian national hypoparathyroidism registry: an overview of hypoparathyroidism in Canada. Endocrine. 72:553-561. 2021
- Diagnosis of Osteoporosis: Clinical and Densitometric Analysis. Canadian Association of Radiologists Journal. 72:326-326. 2021
- Primary Hyperparathyroidism: A Narrative Review of Diagnosis and Medical Management. Journal of Clinical Medicine Journal of Clinical Medicine Journal of Clinical Medicine. 10:1604-1604. 2021
- Exploring Fear of Falling and Exercise Self-Efficacy in Older Women With Vertebral Fractures. Journal of Aging and Physical Activity. 29:219-224. 2021
- Hypoparathyroidism in Pregnancy and Lactation: Current Approach to Diagnosis and Management. Journal of Clinical Medicine Journal of Clinical Medicine Journal of Clinical Medicine. 10:1378-1378. 2021
- Design and topline results of TransCon PTH, a long-acting PTH, phase 2 trial in patients with hypoparathyroidism. Bone Reports. 13:100351-100351. 2020
- Changes in treatment needs of hypoparathyroidism during pregnancy and lactation: A case series. Clinical Endocrinology. 93:261-268. 2020
- SAT-399 Baseline Characteristics from the Observational PARADIGHM Registry of Patients with Chronic Hypoparathyroidism. Journal of the Endocrine Society. 4:sat-399. 2020
- SAT-LB72 Design of the PaTH Forward Phase 2 Trial of TransCon PTH, a Long-Acting PTH, in Patients With Hypoparathyroidism. Journal of the Endocrine Society. 4:sat-lb72. 2020
- SAT-LB72 Design of the PaTH Forward Phase 2 Trial of TransCon PTH, a Long-Acting PTH, in Patients With Hypoparathyroidism. Journal of the Endocrine Society. 4. 2020
- SUN-377 Efficacy of Low Dose Denosumab in Maintaining Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Real World, Prospective Observational Study. Journal of the Endocrine Society. 4:sun-377. 2020
- SUN-377 Efficacy of Low Dose Denosumab in Maintaining Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Real World, Prospective Observational Study. Journal of the Endocrine Society. 4. 2020
- The Effects of Home Exercise in Older Women With Vertebral Fractures: A Pilot Randomized Controlled Trial. Physical Therapy. 100:662-676. 2020
- Are osteoporotic vertebral fractures or forward head posture associated with performance-based measures of balance and mobility?. Archives of Osteoporosis. 14:67. 2019
- Exploring the association between number, severity, location of fracture, and occiput-to-wall distance. Archives of Osteoporosis. 14:27. 2019
- The association between trunk muscle endurance, balance and falls self-efficacy in women with osteoporotic vertebral fractures: an exploratory analysis from a pilot randomized controlled trial. Disability and Rehabilitation. 43:1-7. 2019
- Hypophosphatasia: Canadian update on diagnosis and management. Osteoporosis International. 30:1713-1722. 2019
- Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline. Journal of Clinical Oncology. 37:2270-2290. 2019
- Correction to: Hypophosphatasia: Canadian update on diagnosis and management. Osteoporosis International. 30:1541-1541. 2019
- Score Distributions of the Balance Outcome Measure for Elder Rehabilitation (BOOMER) in Community-Dwelling Older Adults With Vertebral Fracture. Journal of Geriatric Physical Therapy. 42:E87-E93. 2019
- MON-LB091 An Overview of the Etiology, Clinical Manifestations, Management Strategies, and Complications of Hypoparathyroidism from the Canadian National Hypoparathyroidism Registry. Journal of the Endocrine Society. 3:mon-lb091. 2019
- Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus. European Journal of Endocrinology. 180:P1-P22. 2019
- MANAGEMENT OF ENDOCRINE DISEASE: Hypoparathyroidism in pregnancy: review and evidence-based recommendations for management. European Journal of Endocrinology. 180:R37-R44. 2019
- Tools for Enhancement and Quality Improvement of Peer Assessment and Clinical Care in Endocrinology and Metabolism. Journal of Clinical Densitometry. 22:125-149. 2019
- Medical Hypoparathyroidism. Endocrinology and Metabolism Clinics of North America. 47:797-808. 2018
- Build better bones with exercise (B3E pilot trial): results of a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in older women with vertebral fracture. Osteoporosis International. 29:2545-2556. 2018
- FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab. Journal of Bone and Mineral Research. 33:1219-1226. 2018
- Bisphosphonates for prevention of bone loss in women with early breast cancer. Cochrane Database of Systematic Reviews. 2018. 2018
- Hyperparathyroidism. The Lancet. 391:168-178. 2018
- A weekly 35,000 IU vitamin D supplementation improves bone turnover markers in vitamin D deficient Saudi adolescent females. Archives of Osteoporosis. 12:85. 2017
- A weekly 35,000 IU vitamin D supplementation improves bone turnover markers in vitamin D-deficient Saudi adolescent females: response to comments by Ribaldone et al.. Archives of Osteoporosis. 12:101. 2017
- Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries. Osteoporosis and Sarcopenia. 3:64-74. 2017
- Primary hyperparathyroidism: diagnosis and management in 2017. Polskie Archiwum Medycyny Wewnetrznej. 127:438-441. 2017
- Atypical femoral fracture. CMAJ. 189:E542-E542. 2017
- Drug-Related Adverse Events of Osteoporosis Therapy. Endocrinology and Metabolism Clinics of North America. 46:181-192. 2017
- Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ. Journal of Clinical Densitometry. 20:8-24. 2017
- Corrigendum to “Evaluation and Management of Skeletal Health in Celiac Disease: Position Statement”. Canadian Journal of Gastroenterology and Hepatology. 2017:1-1. 2017
- Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporosis International. 28:1-19. 2017
- Primary hyperparathyroidism. Nature Reviews Disease Primers. 2:16033. 2016
- Ostéoporose pendant la ménopause. Journal of Obstetrics and Gynaecology Canada. 38:S465-S483. 2016
- Vitamin D deficiency and biochemical variations among urban Saudi adolescent girls according to season. Saudi Medical Journal. 37:1002-1008. 2016
- Atypical Femoral Fracture Alert Program. Canadian Association of Radiologists Journal. 67:304-305. 2016
- Management of Hypoparathyroidism: Summary Statement and Guidelines. Journal of Clinical Endocrinology and Metabolism. 101:2273-2283. 2016
- Presentation of Hypoparathyroidism: Etiologies and Clinical Features. Journal of Clinical Endocrinology and Metabolism. 101:2300-2312. 2016
- Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015. Osteoporosis International. 27:853-859. 2016
- Bilateral atypical femoral fractures: how much symmetry is there on imaging?. Skeletal Radiology. 44:1579-1584. 2015
- Response to Comments on “Diagnosis and Management of Osteoporosis of the Jaw: A Systematic Review and International Consensus”. Journal of Bone and Mineral Research. 30:1941-1941. 2015
- Persistence with denosumab therapy among osteoporotic women in the Canadian patient-support program. Current Medical Research and Opinion. 31:1391-1401. 2015
- Response to Comments on “Diagnosis and Management of Osteoporosis of the Jaw: A Systematic Review and International Consensus”. Journal of Bone and Mineral Research. 30:1116-1117. 2015
- Atypical Femoral Fractures: A Teaching Perspective. Canadian Association of Radiologists Journal. 66:102-107. 2015
- Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery. European Journal of Endocrinology. 172:527-535. 2015
- Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID). Canadian Journal of Psychiatry. 60:189-199. 2015
- Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus. Journal of Bone and Mineral Research. 30:3-23. 2015
- OSTEONECROSIS OF THE JAW: AN UPDATE FOR DENTISTS.. Journal of the Canadian Dental Association. 81:f19. 2015
- Medical Management of Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism. 99:3607-3618. 2014
- Archivée: Ostéoporose pendant la ménopause. Journal of Obstetrics and Gynaecology Canada. 36:841-843. 2014
- Archivée: Prise en charge de la ménopause. Journal of Obstetrics and Gynaecology Canada. 36:834-838. 2014
- Managing Menopause. Journal of Obstetrics and Gynaecology Canada. 36:830-833. 2014
- RETIRED: Osteoporosis in Menopause. Journal of Obstetrics and Gynaecology Canada. 36:839-840. 2014
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Alendronate (ALN) on Bone Mineral Density (BMD) and Bone Turnover in Perimenopausal Women With Low BMD. Journal of Clinical Densitometry. 17:425-426. 2014
- Development of Recommendations for Radiologists Regarding the Evaluation and Management of Osteoporosis When Reporting Major Osteoporotic Fractures in Those Over Age 50. Journal of Clinical Densitometry. 17:420-420. 2014
- Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.. Canadian Family Physician. 60:324-333. 2014
- The bisphosphonates in the treatment of osteoporosis Expected Benefits, potential harms and therapeutic time off. Canadian Family Physician. 60:E197-E207. 2014
- Improving Management of Osteoporosis through Simple Changes in Reporting Fragility Fractures. Canadian Association of Radiologists Journal. 64:278-280. 2013
- Approach to diagnosing celiac disease in patients with low bone mineral density or fragility fractures: multidisciplinary task force report.. Canadian Family Physician. 59:1055-e448. 2013
- Corrigendum. Current Medical Research and Opinion. 29:1211-1211. 2013
- Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis. Current Medical Research and Opinion. 29:205-216. 2013
- Medical Management of Primary Hyperparathyroidism. Journal of Clinical Densitometry. 16:60-63. 2013
- Supplement on Primary Hyperparathyroidism. Journal of Clinical Densitometry. 16:3-3. 2013
- Hypoparathyroidism. Best Practice and Research in Clinical Endocrinology and Metabolism. 26:517-522. 2012
- Diagnosis and management of primary hyperparathyroidism. British Medical Journal BMJ (Clinical research ed.). 344:e1013-e1013. 2012
- Hypocalcemia: updates in diagnosis and management for primary care.. Canadian Family Physician. 58:158-162. 2012
- Evaluation and Management of Skeletal Health in Celiac Disease: Position Statement. Canadian Journal of Gastroenterology. 26:819-829. 2012
- Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. Journal of Bone and Mineral Research. 26:2317-2337. 2011
- Primary hyperparathyroidism. CMAJ. 183:E685-E689. 2011
- Bisphosphonate-associated Osteonecrosis of the Jaw in Ontario: A Survey of Oral and Maxillofacial Surgeons. Journal of Rheumatology. 38:1396-1402. 2011
- Official Positions for FRAX® Bone Mineral Density and FRAX® Simplification. Journal of Clinical Densitometry. 14:226-236. 2011
- Primary hyperparathyroidism: Update on presentation, diagnosis, and management in primary care.. Canadian Family Physician. 57:184-189. 2011
- Asymptomatic Primary Hyperparathyroidism—Commentary on Current Management. Journal of Clinical Densitometry. 13:321-323. 2010
- Osteonecrosis of the jaw and bisphosphonates. British Medical Journal BMJ (Clinical research ed.). 340:c246-c246. 2010
- Alendronate Therapy in Men With Primary Hyperparathyroidism. Endocrine Practice. 15:705-713. 2009
- Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop. Journal of Clinical Endocrinology and Metabolism. 94:335-339. 2009
- The Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism Revisited. Journal of Clinical Endocrinology and Metabolism. 94:333-334. 2009
- Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw (vol 35, pg 1391, 2008). Journal of Rheumatology. 35:1688-1688. 2008
- Osteonecrosis of the jaw: new developments in an old disease.. Journal of Rheumatology. 35:547-549. 2008
- Cancer Treatment–Related Bone Loss: A Review and Synthesis of the Literature. Current Oncology. 15:30-40. 2008
- Dual-Energy X-Ray Absorptiometry Technical Issues: The 2007 ISCD Official Positions. Journal of Clinical Densitometry. 11:109-122. 2008
- Islam's forgotten contributions to medical science. CMAJ. 176:1467-1468. 2007
- Middle East and North Africa consensus on osteoporosis.. Journal of Musculoskeletal Neuronal Interactions. 7:131-143. 2007
- Recommendations for Bone Mineral Density Reporting in Canada: A Shift to Absolute Fracture Risk Assessment. Journal of Clinical Densitometry. 10:120-123. 2007
- Standards and Guidelines for Technologists Performing Central Dual-Energy X-Ray Absorptiometry. Journal of Clinical Densitometry. 10:189-195. 2007
- Recognizing and reporting vertebral fractures: reducing the risk of future osteoporotic fractures.. Canadian Association of Radiologists Journal. 58:27-36. 2007
- Management of osteoporosis in men: an update and case example. CMAJ. 176:345-348. 2007
- Bone Mineral Density Assessment in Premenopausal Women. Women's Health Women's health (London, England). 2:639-645. 2006
- Premenopausal women and low bone density.. Canadian Family Physician. 52:743-747. 2006
- Alendronate in Primary Hyperparathyroidism: Efficacy in Men and Pre-Menopausal Women. Journal of Clinical Densitometry. 9:239-239. 2006
- Anabolic Agents: A New Chapter in the Management of Osteoporosis. Journal of Obstetrics and Gynaecology Canada. 28:136-141. 2006
- Standards for Performing DXA in Individuals With Secondary Causes of Osteoporosis. Journal of Clinical Densitometry. 9:47-57. 2006
- Prevalence of Vitamin D Inadequacy among Postmenopausal North American Women Receiving Osteoporosis Therapy. Journal of Clinical Endocrinology and Metabolism. 90:3215-3224. 2005
- Recommendations for bone mineral density reporting in Canada.. Canadian Association of Radiologists Journal. 56:178-188. 2005
- Management of Low Bone Mineral Density in Premenopausal Women. Journal of Obstetrics and Gynaecology Canada. 27:345-349. 2005
- Alendronate in Primary Hyperparathyroidism: A Double-Blind, Randomized, Placebo-Controlled Trial. Journal of Clinical Endocrinology and Metabolism. 89:3319-3325. 2004
- Standards and Guidelines for Performing Central Dual-Energy X-Ray Absorptiometry in Premenopausal Women, Men, and ChildrenA Report From the Canadian Panel† of the International Society of Clinical Densitometry. Journal of Clinical Densitometry. 7:51-63. 2004
- Asymptomatic Primary Hyperparathyroidism: Standards and Guidelines For Diagnosis and Management in Canada. Endocrine Practice. 9:400-405. 2003
- Advances in osteoporosis therapy. 2003 update of practical guidelines.. Canadian Family Physician. 49:441-447. 2003
- Standards and Guidelines for Performing Central Dual X-Ray Densitometry from the Canadian Panel of International Society for Clinical Densitometry. Journal of Clinical Densitometry. 5:435-445. 2002
- The 2002 Canadian bone densitometry recommendations: take-home messages.. CMAJ. 167:1141-1145. 2002
- Standards and Guidelines for Performing Central Dual X-Ray Densitometry from the Canadian Panel of International Society for Clinical Densitometry. Journal of Clinical Densitometry. 5:247-257. 2002
- Bone Densitometry: Applications and Limitations. Journal of Obstetrics and Gynaecology Canada. 24:476-484. 2002
- Skeletal Effects of Primary Hyperparathyroidism. Endocrine Practice. 6:385-388. 2000
- Primary hyperparathyroidism: pathophysiology and impact on bone.. CMAJ. 163:184-187. 2000
- Primary Hyperparathyroidism: Diagnosis and Management. Endocrine Practice. 3:22-26. 1997
-
chapter
- Hypoparathyroidism in Pregnancy. 143-153. 2020
- Hypoparathyroidism. Frontiers of Hormone Research. 109-126. 2019
- Magnesium Homeostasis. 173-178. 2018
- Hypercalcemia. 91-105. 2017
- Chapter 37 Medical Management of Primary Hyperparathyroidism. 533-553. 2015
- Chapter 56 Treatment of Hypoparathyroidism with Calcium and Vitamin D. 807-810. 2015
- Medical Management of Primary Hyperparathyroidism. 533-553. 2015
- Role of Magnesium in Parathyroid Physiology. 61-67. 2015
- Treatment of Hypoparathyroidism with Calcium and Vitamin D. 807-810. 2015
- Primary Hyperparathyroidism: Asymptomatic Medical Management. 93-102. 2012
-
conference paper
- Osteoporosis treatment rate following hip fracture in a community hospital. Archives of Osteoporosis. 2021
- EFFICACY OF LOW DOSE DENOSUMAB IN MAINTAINING BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: A REAL WORLD, PROSPECTIVE OBSERVATIONAL STUDY. Osteoporosis International. S506-S507. 2020
- Efficacy of low dose Denosumab in maintaining bone mineral density in postmenopausal women with osteoporosis: a real world, prospective observational study. Journal of Bone and Mineral Research. 250-250. 2020
- Barriers, Facilitators, Needs And Goals Of Exercise For People With Osteoporosis. Medicine and Science in Sports and Exercise Medicine and science in sports. 417-417. 2020
- Trunk Muscle Endurance in Women with Osteoporotic Vertebral Fractures: an Exploratory Analysis from a Pilot Randomized Controlled Trial. Journal of Bone and Mineral Research. 277-277. 2018
- OP0344 Frame study: the foundation effect of rebuilding bone with one year of romosozumab leads to continued lower fracture risk after transition to denosumab. Annals of the Rheumatic Diseases. 217-218. 2018
- Build better bones with exercise: feasibility of a multicenter randomized controlled trial of 12 months of home exercise in women with a vertebral fracture.. Journal of Bone and Mineral Research. S258-S259. 2017
- The Placebo-Controlled Fracture Study in Postmenopausal Women with Osteoporosis: The Foundation Effect of Rebuilding Bone with One Year of Romosozumab Leads to Continued Lower Fracture Risk after Transition to Denosumab. Arthritis and Rheumatology. 2017
- OSTEOPOROSIS THERAPY: LONG-TERM BENEFITS AND RISKS. Osteoporosis International. S425-S425. 2015
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Alendronate on Bone Mineral Density and Bone Remodelling in Perimenopausal Women With Low Bone Mineral Density. Journal of Obstetrics and Gynaecology Canada. 976-982. 2014
- Atypical Femoral Fractures: Radiographic and Histomorphometric Features in 19 Patients. Journal of Clinical Densitometry. 402-403. 2014
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Alendronate (ALN) on Bone Mineral Density (BMD) and Bone Turnover in Perimenopausal Women with Low BMD. Endocrine Reviews Recent Progress in Hormone Research. 2014
- Cinacalcet Normalizes Serum Calcium in a Randomized, Placebo-Controlled Clinical Study in Patients with Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy. Endocrine Reviews Recent Progress in Hormone Research. 2014
- 12-MONTH PERSISTENCE WITH DENOSUMAB THERAPY AMONG OSTEOPOROTIC WOMEN IN THE CANADIAN PATIENT-SUPPORT PROGRAM. Osteoporosis International. S221-S221. 2014
- OSTEONECROSIS OF THE JAW: REPORT FROM THE INTERNATIONAL ONJ TASK FORCE. Osteoporosis International. S148-S149. 2014
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFECTS OF ALENDRONATE (ALN) ON BONE MINERAL DENSITY (BMD) AND BONE TURNOVER IN PERIMENOPAUSAL WOMEN WITH LOW BMD. Osteoporosis International. S55-S56. 2014
- DEVELOPMENT OF RECOMMENDATIONS FOR RADIOLOGISTS REGARDING THE EVALUATION AND MANAGEMENT OF OSTEOPOROSIS WHEN REPORTING MAJOR OSTEOPOROTIC FRACTURES IN THOSE OVER AGE 50. Osteoporosis International. S47-S48. 2014
- International Consensus on Diagnosis and Management of Osteonecrosis of the Jaw. Journal of Bone and Mineral Research. 2013
- HYPERPARATHYROIDISM. Osteoporosis International. 659-660. 2012
- EXPLORING DIFFERENCES IN BONE DENSITY AND STRUCTURE BETWEEN PATIENTS ON BISPHOSPHONATES WITH ATYPICAL FEMUR FRACTURES AND OTHER POPULATIONS. Osteoporosis International. 351-352. 2011
- Medical Management of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop. Journal of Clinical Endocrinology and Metabolism. 373-381. 2009
- Alendronate in primary hyperparathyroidism: Efficacy in men and premenopausal women.. Journal of Bone and Mineral Research. S438-S438. 2006
- Alendronate in primary hyperparathyroidism: Efficacy in men and premenopausal women. Osteoporosis International. S314-S314. 2006
- Vitamin D insufficiency is highly prevalent among North American women treated for osteoporosis.. Journal of Bone and Mineral Research. S342-S343. 2004
- Bone Densitometry in Premenopausal Women. Journal of Clinical Densitometry. 85-92. 2004
- A double blind randomized placebo controlled trial of alendronate in primary hyperparathyroidism.. Journal of Bone and Mineral Research. S98-S98. 2003
- A double blind randomized placebo controlled trial of alendronate in primary hyperparathyroidism.. Journal of Bone and Mineral Research. S165-S165. 2002
- A double blind randomized placebo controlled trial of alendronate in primary hyperparathyroidism.. Journal of Bone and Mineral Research. S226-S226. 2001